Disclaimer: This web site provides details on our corporate clinical trial disclosure policy and commitments and access to information on clinical trial protocols, study results, and plain (lay) language study results summaries.
What is a Clinical Trial?
A clinical trial is a research study that explores whether a medical treatment or device is safe and effective for humans. It plays a critical role in the process of bringing new therapies to patients.
Trials conducted during clinical development generate thousands of pieces of data that are generally used by regulatory agencies, to determine approval for use of the therapy and in which medical indications.
Daiichi Sankyo is committed to the appropriate disclosure of information from its clinical trials. We believe that making protocols information and clinical trial data available to researchers, healthcare professionals, patients, academics and others, in appropriate formats, advances science and medicine. These interactions hold promise for the improvement of public health, increased knowledge, and deeper bonds of trust.
We disclose information from our clinical trials through registration and postings on widely accepted public clinical trial registries, in line with our corporate commitments as well as international and national regulatory requirements and disclosure norms established by global and regional pharmaceutical industry associations.
Phase I to IV clinical trials are disclosed in Clinical Trial Registries accessible to the public free of charge in line with applicable regulations. Each registry contains adequate trial information to inform prospective clinical trial volunteers, health care practitioners and the general public of the clinical trial title, design, identification / registration number, description and purpose, medical condition or disease being studied, key eligibility criteria, recruitment status, trial sites and contact for information on enrolment.
In addition to routinely publishing clinical research in scientific journals and collaborating with academic researchers, Daiichi Sankyo also complies with applicable regulations and the principles set forth by the European Federation of Pharmaceutical Industries Association (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) to responsibly share clinical trial data upon formal request and approval by an independent review panel.
Links to Clinical Trial Registries and Data Sharing Portal
- US: ClinicalTrials.gov
- EU: EU Clinical Trial Register
- Japan: JapicCTI
- Japan: jRCT
- WHO: ICTRP
- Global Clinical Research Data Sharing Platform: Vivil
Find a Clinical Study: The National Institute for Health Research (NIHR) provides a comprehensive list of clinical research studies running in the UK.
Investigator Initiated Studies (IIS) and Collaborative Research (CR)
Daiichi Sankyo is committed to supporting research to address unmet medical needs of patients around the world.
Daiichi Sankyo offers the opportunity for external researchers who are interested in conducting their own research related to Daiichi Sankyo therapeutic areas of interest to submit an independent research concept that is subsequently reviewed by an internal review committee. Daiichi Sankyo may provide funding and other forms of support, such as clinical trial material, to support studies initiated and sponsored by external researchers.
If you are interested or ready to submit a concept, please review information on DaiichiSankyo-ESR.com
DSC/22/0075 - April 2022